Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Preoperative octreotide treatment of patients with growth hormone producing pituitary adenomas.

Trial Profile

Preoperative octreotide treatment of patients with growth hormone producing pituitary adenomas.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jul 2014

At a glance

  • Drugs Octreotide (Primary)
  • Indications Acromegaly
  • Focus Therapeutic Use
  • Acronyms POTA
  • Most Recent Events

    • 20 Oct 2011 Actual end date added as May 2010 as reported by ClinicalTrials.gov.
    • 20 Oct 2011 Actual end date added as May 2010 as reported by ClinicalTrials.gov.
    • 20 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top